Skip to content

Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?

Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00984841
Enrollment
467
Registered
2009-09-25
Start date
2009-01-31
Completion date
2009-07-31
Last updated
2009-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Diabetes Mellitus targeted mailing

Brief summary

The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.

Detailed description

Diabetes care in the US is less than optimal. Some authors have found that targeted patient letters are also an effective tool to improve outcomes when they are part of a comprehensive disease management plan. Local patient satisfaction surveys had revealed that many patients had sub-optimal understanding of diabetes measures and of the importance of controlling these measures to reduce diabetic complications. We wondered if tailored patient letters and enclosed lab orders when due might increase patient awareness of diabetes measures and increase patient engagement.We hypothesized that the addition of targeted patient letters with enclosed lab orders to an ongoing performance improvement program would further improve diabetes care. We conducted a randomized controlled study of tailored patient letters and diabetes lab orders at our two resident-based clinics.

Interventions

OTHERTailored letter

Sponsors

Scranton-Temple Residency Program
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* All active patients age 18 to 75 years with a diagnosis of diabetes mellitus were eligible. * An active patient was defined as one having an ICD-9 code on the active problem list identifying the patient as diabetic, and a progress note in the EMR associated with an office visit within the prior 12 months.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Diabetes summary quality measure4 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026